Clinical Trial Update: Post-Market Clinical Follow Up Study With Navitor Valve

View source ↗

Summary

Post-market clinical follow-up study for Abbott's Navitor transcatheter heart valve in patients with aortic stenosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Drugs mentioned

• Navitor transcatheter heart valve

Snippet

Sponsor: Abbott Medical Devices | Conditions: Aortic Stenosis | Status: RECRUITING